SCHEMBL16574871

SCHEMBL16574871

O=Cc1cccc(C2CCC(C(=O)O)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ AKR1C3 P42330 1/20 0.50
▸ AKR1C1 Q04828 1/20 0.50
▸ DRD2 P14416 1/20 0.45
▸ DRD1 P21728 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ DRD5 P21918 1/20 0.45
▸ DRD3 P35462 1/20 0.45
▸ UNG P13051 1/20 0.45
▸ KMO O15229 1/20 0.43
▸ PDE4A P27815 2/20 0.42
▸ PDE4B Q07343 2/20 0.42
▸ PDE4C Q08493 2/20 0.42
▸ PDE4D Q08499 2/20 0.42
▸ CYP4F2 P78329 1/20 0.41
▸ CYP4A11 Q02928 1/20 0.41
▸ TRIM24 O15164 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40
▸ NOTUM Q6P988 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10373192 0.87 DRD2 (0.54) DRD2DRD1DRD4DRD5DRD3
SCHEMBL12212992 0.80 NPC1 (0.62) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL12212988 0.80 NPC1 (0.62) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL3437970 0.80 DRD2 (0.58) DRD2DRD1DRD4DRD5DRD3
SCHEMBL3438198 0.78 DRD2 (0.57) DRD2DRD1DRD4DRD5DRD3
SCHEMBL21731690 0.78 NPC1 (0.54) NPC1RAB9AAKR1C3AKR1C1DRD4
SCHEMBL7715894 0.78 NPC1 (0.54) NPC1RAB9AAKR1C3AKR1C1KMO
SCHEMBL664284 0.77 NPC1 (0.79) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL3516198 0.77 NPC1 (0.79) NPC1RAB9AAKR1C3AKR1C1PDE4A
SCHEMBL2511695 0.77 NPC1 (0.79) NPC1RAB9AAKR1C3AKR1C1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464166-B2 Production and use of 3,4' and 4,4'-dimethylbiphenyl isomers EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-10-11 — — US disclosed
US-20150080546-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers EXXONMOBIL CHEMICAL PATENTS INC. 2015-03-19 — — US disclosed
US-20150080545-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers EXXONMOBIL CHEMICAL PATENTS INC. 2015-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080546-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers CYP4B1, HPD, DDT NPC1 4871/4885RAB9A 4370/4885AKR1C3 187/4885
US-20150080545-A1 Production and Use of 3,4' and 4,4'-Dimethylbiphenyl Isomers CYP4B1, HPD, DDT NPC1 4871/4885RAB9A 4370/4885AKR1C3 187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback